Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Verbal Fluencies and Fampridine Treatment in Multiple Sclerosis.
Preliminary validation of the short physical performance battery in older adults with multiple sclerosis: secondary data analysis.
Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxRγ Receptor Activation.
Tumefactive demyelinating disease with isolated spinal cord involvement.
Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.
Markedly Increased IP-10 Production by Blood-Brain Barrier in Neuromyelitis Optica.
Neuronal activity biases axon selection for myelination in vivo.
Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.
Corticospinal tract integrity measured using transcranial magnetic stimulation and magnetic resonance imaging in neuromyelitis optica and multiple sclerosis.
Pain: Comorbidity of neuropathic pain and migraine in patients with multiple sclerosis.
Cerebrospinal fluid analysis in the context of CNS demyelinating diseases.
An Optimized Immunohistochemistry Technique Improves NMO-IgG Detection: Study Comparison with Cell-Based Assays.
Volumetric MRI assessment of brain and spinal cord in finnish twins discordant for multiple sclerosis.
Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.
Laquinimod in the treatment of multiple sclerosis: a review of the data so far.
Remyelinating strategies in multiple sclerosis.
Current role of chemotherapy and bone marrow transplantation in multiple sclerosis.
Serum proteomics in multiple sclerosis disease progression.
Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.
An updated role of microRNA-124 in central nervous system disorders: a review.
Pain and Cognition in Multiple Sclerosis.
Multiple sclerosis: evaluation of purine nucleotide metabolism in central nervous system in association with serum levels of selected fat-soluble antioxidants.
The azetidine derivative, KHG26792 protects against ATP-induced activation of NFAT and MAPK pathways through P2X7 receptor in microglia.
Infection as an Environmental Trigger of Multiple Sclerosis Disease Exacerbation.
Remyelination in multiple sclerosis: realizing a long-standing challenge.

Pages